GlassScriptPhysician profile
Adrian Abreu
NPI 1679070262
$548.37
in general payments reported to CMS, 2019-2025
12 companies · $425 in 2025
The $425 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $90.84 · 2024: $32.51 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $548.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $548.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $98.91 | 2025 | Veozah |
| Abbott Laboratories | $90.84 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Hologic Sales and Service, LLC | $68.56 | 2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $60.75 | 2025 | |
| Dexcom, INC. | $48.47 | 2025 | Dexcom G6 Transmitter |
| Biogen, INC. | $42.02 | 2025 | Zurzuvae |
| Mayne Pharma Commercial LLC | $30.92 | 2025 | |
| Organon LLC | $30.49 | 2024-2025 | Nexplanon |
| Smith+Nephew, INC. | $24.60 | 2024 | Pico 14, Renasys Touch |
| Optumhealth Care Solutions, LLC | $24.08 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Organogenesis INC. | $16.48 | 2025 | Nushield |
| Channel Medsystems, INC. | $12.25 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrian Abreu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.